MEDICINOVA, INC. (MNOV) Return on equity 2021–2025
MEDICINOVA, INC. (MNOV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-28.9%FY2025 · since FY2021: -12.1% → -28.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -28.9% | — |
| FY2023 | -13.7% | — |
| FY2021 | -12.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More MNOV financial trends
MNOV RevenueMNOV Net incomeMNOV Net marginMNOV Gross profitMNOV Gross marginMNOV Operating incomeMNOV Operating marginMNOV Operating cash flowMNOV Free cash flowMNOV Capital expendituresMNOV Stock buybacksMNOV Dividends paidMNOV Total assetsMNOV Total liabilitiesMNOV Shareholders’ equityMNOV overview →